*HEXZA 3298*
Ethanol segment:
~Turnover for the quarter increased 102.7% to RM13.36 million
from RM6.59 million in the corresponding quarter last year mainly
due to increase in sales volume by 117.8%. This was due to the
outbreak of the Covid-19. In the absence of a vaccine or effective antiviral drugs, ethanol is one of the recommended ingredients for
hand sanitiser, hence the demand for our ethanol products has
increased substantially from February 2020.
Profit before tax for ethanol segment increased by RM3.14 million
to RM4.37 million from RM1.23 million mainly due to significant
increase in sales volume.
~As at 25 June 2020, the *aggregate value of our investment
portfolio was RM21.66 million higher* as compared to the reported
value as at 31 March 2020.
Save for the above, there are no material events subsequent to
the end of period reported on to the date of this report which have
not been reflected in the financial statements for the quarter
ended 31 March 2020.

“With the current outbreak of a new coronavirus strain, the demand for our ethanol products has increased substantially. Our ethanol segment’s financial results is expected to benefit significantly which should help offset any potential downturn from the resins segment.”

“There are only two major manufacturers of ethanol in Malaysia, namely Hexza and Fermpro Sdn Bhd, a subsidiary of Nylex (Malaysia) Berhad.”

I sold Duopharma at 3.55 today n buy Hexza @1.28! Just to make a record here!

My call! MFCB, Duopharma, now is Hexza! Clock is clicking!

Don't buy this stock if you are speculator! Haha!

卧虎藏龙! You will be surprised if you know some of the sifus here r more than qualified as just research analyst!

高手如云!